Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Pharma Consulting

Close Icon

Hot topics

Thought leadership

Research and development strategy

Close Icon

Events

Conferences 2019

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

Biomedtracker: follow the drug development process

See the drug development process through analysts’ eyes: understand important upcoming milestones and past events that impact the likelihood of drug approval.

Biomedtracker provides real-time analysis of major market-moving events in the pharma and biotech industries. With catalyst tracking and expert insights, you stay on top of breaking events, what’s in the drugs pipeline, upcoming milestones, clinical trial results and their impact on the markets you care about

Request a free demo

Stay up to date
Get ahead of the competition
Conference coverage

Tracking drug development

Stay on the cutting edge of major market events in drug development. Powered by real-time intelligence, Biomedtracker’s web-based platform tracks and analyzes clinical and regulatory developments so you can quickly and accurately assess a drug's probability of technical success.

How it helps
Biomedtracker's exclusive likelihood of approval analyses highlight the "bottom line" impact of today’s news on your business. Our expert industry analysts draw insights from closely monitoring companies, clinical trials, deals, and regulatory meetings to capture and report on the most critical events.

How it works
Biomedtracker’s intuitive interface features the latest, industry-acclaimed insights, all at your fingertips. We track impactful future catalysts, and then analyze these commercial, clinical, and regulatory activities as they happen, and present them to you via an easily searchable interface that keeps you at the top of your game.

Our analysts attend the medical and investor meetings that matter to you, bringing you not just the news, but vital information on how it impacts your bottom line.

Learn more about the next generation of Biomedtracker

Request a demo

What's included

Stay up to date

Real-time tracking and analysis of every event in drug development; customized email alerts

Get ahead of the competition

Monitor all aspects of the market from one place, from drugs, to targets, to trials, and more

Conference coverage

Medical and investor conference planners and post-reports cover major meeting developments

Forecast your market’s future

Predict how FDA Panel Members might vote with AdComm Insight

Leverage analysts’ knowledge

Exclusive likelihood of approval analyses and access to our expert team.

Biomedtracker

Biomedtracker Q3 2019 Outlook Report Extract

29 Jul 2019

In this report, we cover catalysts from 27 drugs, devices and diagnostics expected to occur in Q3 2019. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided. These data points were provided using a combination of Pharmapremia, Informa’s drug development benchmarking product utilizing Biomedtracker’s LOA data to assist in informed decisions about drug pipeline prioritization, partnerships, and acquisitions, and drug approval data from Biomedtracker.

Topic Drug development landscape Drug review Research Strategy

Single report
Datamonitor Healthcare, Biomedtracker, Pharmapremia

2019 Q3 Outlook Webinar

By Hardik Patel 15 Jul 2019

Informa Pharma Intelligence presents an essential, free session during which industry analysts present their data-driven views about what to expect during the third quarter of 2019.

Topic immuno-oncology Infectious diseases

Full video
Meddevicetracker, Biomedtracker

When Part of the Picture Isn't Enough

05 Jul 2019

Staying on top of what’s going in the competitive Medtech market and getting a complete view of the competitive landscape and current market trends is critical to your business. Often, this essential information is fragmented and diﬃcult to ﬁnd, and gathering and synthesizing it is tedious and time consuming. Now, Biomedtracker puts this critical information at your ﬁngertips, saving you time and eﬀort. The new “Associated Products” section on relevant Biomedtracker Drug Proﬁle pages shows you the full competitive landscape – including drugs, devices, and diagnostics – with a single search.

Topic Business strategies Medtech

Single report
Datamonitor Healthcare, Biomedtracker

Q1 Outlook Webinar: Key Catalysts and their Impact on Pharma Markets

By Michael Haydock 02 Jul 2019

Find out which market-moving events and catalysts to watch for during the Q1 Outlook Webinar - Key catalysts and their impact on pharma markets.

Topic Drug approval Drug development landscape Drug review

Full video
Biomedtracker

Biomedtracker: Catalyst Roundup 2018 Q4

02 Jul 2019

A Review of Select Catalysts from Last Quarter’s Outlook Report.

Topic Clinical trials Drug approval Drug review Drug development landscape

View infographic
Meddevicetracker, Biomedtracker

Q2 2019 Outlook Report

03 May 2019

In this report, we cover catalysts from 25 drugs, devices and diagnostics expected to occur in Q2 2019. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided.

Topic Drug approval Drug development landscape Drug review

Single report
Biomedtracker, Datamonitor Healthcare

December 2018 National Influenza Week

10 Apr 2019

3 – 9 December is National Influenza Vaccination Week, a national awareness week focused on highlighting the importance of influenza vaccination. In this free KOL Insight Interview excerpt from Datamonitor Healthcare, read what key opinion leaders from the UK and US in Infectious Diseases have to say about current efforts to combat influenza with seasonal influenza vaccines:

Topic Influenza virus Infectious diseases

Single report
Biomedtracker

Biomedtracker 2018 Early Outlook Report

10 Apr 2019

What's on the horizon for pharma in 2018? Find out with Biomedtracker's Early 2018 Outlook Report extract. Download free extracts from this essential report, which investigates the catalysts expected to occur in the first part of the year for 21 different drugs.

Topic Drug development landscape

Single report
Biomedtracker, Meddevicetracker

Biomedtracker: Early 2019 Outlook Report Extract

10 Apr 2019

In this report, we cover catalysts from 23 drugs, devices and diagnostics expected to occur in early 2019.

Topic Drug approval Drug review Medtech

Single report
Biomedtracker

Q4 Outlook Webinar - Key Catalysts and their Impact on Pharma Markets

By Dominique Fontanilla 19 Nov 2018

Understand important upcoming milestones that will impact the likelihood of drug approval or future sales potential for key therapies during a free webinar from Informa Pharma Intelligence, "Q4 Outlook Webinar - Key Catalysts and their Impact on Pharma Markets".

Topic Drug development landscape

Full video
Biomedtracker

Biomedtracker Q4 2018 Outlook Report

19 Oct 2018

Find out what’s in store for the remainder of 2018 with your copy of the Biomedtracker Q4 2018 Outlook Report Extract. This essential analysis of expected Q4 catalysts for 27 drugs is now available to you – for free. Drawn from the full report of the same name, this vital resource explores the likelihood of phase/PDUFA review success and overall Likelihood of Approval (LOA) based on a drug’s phase, drug class, and disease group.

Topic Drug development landscape

Single report
Biomedtracker

Pharma Partnering Trends Revealed Whitepaper

12 Oct 2018

Make the most of BIO-Europe 2018 with essential partnering information from Informa Pharma Intelligence. Our insightful whitepaper, Pharma Partnering Trends Revealed: 2018 Edition, contains critical information on the landscape for biotech partnerships, and is now available for you to download – free.

View white paper
Biomedtracker

Biomedtracker Q3 2018 Outlook Infographic

22 Aug 2018

For a look at the outcomes for predicted Q2 2018 catalysts, we invite you to download a free copy of the data-rich Catalyst Roundup infographic from Biomedtracker. This informative graphic takes a look at the outcomes for two major catalysts featured in Biomedtracker’s insightful Q2 2018 Outlook Report.

Topic Drug development landscape

View infographic
Biomedtracker

Biomedtracker Q3 2018 Outlook Report Extract

15 Aug 2018

Download an extract of the data-rich resource: Biomedtracker’s Q3 2018 Outlook Report. This latest installment in Biomedtracker’s ongoing quarterly reports contains expected drug catalyst predictions, important clinical and regulatory milestones, and Large Impact catalysts for the upcoming quarter.

Topic Drug development landscape

Single report
Citeline, Scrip, Biomedtracker, Datamonitor Healthcare

ASCO Essentials Webinar 2018 Recording

By Mary Jo Laffler 29 May 2018

Just in time for your 2018 ASCO Annual Meeting planning, join analysts from Datamonitor Healthcare, Biomedtracker, Citeline, Scrip, and Pink Sheet for their expert opinions on what you need to know to get the most from the meeting. Let our experts present their top picks from the thousands of abstracts being presented at ASCO.

Topic Clinical trials

Full video

Meet the team

Management

Patricia Reilly

Management, VP, Intelligence Alliances and Product Unification

Patricia specializes in

CNS
Immunology & Inflammation
Oncology

+27 year(s) experience

Management

Gail Parziale

Management, Head of Intelligence Editorial Operations

Gail specializes in

Commercial Strategy
Clinical Trials

+22 year(s) experience

Analyst

Rachel Meighan-Mantha

Analyst, Principal Analyst

Rachel specializes in

Oncology
Clinical Trials

+22 year(s) experience

See all analysts

Next steps

Request a Demo

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

How can we help you?

Our team is always happy to hear from you. Please call us at:

US Toll-Free : +1 888 670 8900
US Toll : +1 908 547 2200
UK & Europe : +44 (20) 337 73737
Australia : +61 2 8705 6907
Japan : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Tracking drug development

What's included